Clinical trials
Phase 3 Diabetes Mellitus, Type 2 trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 13 |
| 2009 | 9 |
| 2010 | 12 |
| 2011 | 3 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 87 |
| Terminated | 12 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 27 |
| AstraZeneca | 16 |
| Eli Lilly and Company | 13 |
| Boehringer Ingelheim | 9 |
| Takeda | 9 |
| Sanofi | 6 |
| Hoffmann-La Roche | 4 |
| Janssen Research & Development, LLC | 4 |
| Lexicon Pharmaceuticals | 4 |
| Bayer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 108 |
| Diabetes Mellitus | 34 |
| Glucose Metabolism Disorders | 8 |
| Metabolic Diseases | 7 |
| Renal Insufficiency, Chronic | 6 |
| Cardiovascular Diseases | 5 |
| Endocrine System Diseases | 5 |
| Hyperglycemia | 5 |
| Kidney Diseases | 5 |
| Coronary Artery Disease | 3 |
Trials
Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.